The U.S. government agency, the Defense Health Agency (DHA), awarded a $1,516.20 fixed-price with economic price adjustment delivery order contract to Medtronic Inc., through its Medtronic USA, Inc. division, to provide biologics - DBM-TS-GRAFTON DBF. This contract has an ultimate completion date of October 15, 2024. Medtronic is a global medical technology company that specializes in developing and manufacturing innovative medical devices and therapies. The company has a significant...
The U.S. government has awarded a $5,702.85 fixed-price delivery order contract to Medtronic Inc., through its Medtronic USA, Inc. division, for the supply of Biologics - DBM-TS-OTI Grafton DBM Matrix medical products. This contract was awarded by the Defense Health Agency (DHA), a component of the Department of Defense (DoD) that oversees the Military Health System. The contract has an ultimate completion date of December 9, 2024 and does not have a set-aside designation. Medtronic is a...
The U.S. government has awarded a $3,790.50 fixed-price delivery order contract to Medtronic Inc., through its Medtronic USA, Inc. division, for the supply of BIOLOGICS - DBM-TS-GRAFTON DBF medical products. This contract was issued by the Defense Health Agency (DHA), a component of the Department of Defense. The contract has no set-aside designation and runs through July 10, 2024. Medtronic is a global leader in medical technology, providing a wide range of innovative medical devices and...
This is a federal contract award from the Defense Health Agency (DHA) to Medtronic Inc., through its Medtronic USA, Inc. division, for the delivery of BIOLOGICS - DBM-TS-MAGNIFUSE DBM medical devices. The contract is a Delivery Order with a fixed price and economic price adjustment, has a ceiling value of $14,820.00, and has a completion date of September 6, 2024. The contract is not designated as a set-aside. Medtronic, a global leader in medical technology, has a significant Indefinite...
This is a federal contract award to Medtronic Inc., through its Medtronic USA, Inc. division, for the delivery of BIOLOGICS - DBM-TS-OTI GRAFTON PLUS DBM medical supplies. The contract was awarded by the Medical Supply Chain, a component of the Defense Health Agency (DHA), and has a ceiling value of $3,484.60 with a fixed price with economic price adjustment pricing type. The contract was awarded on November 8, 2024, with an ultimate completion date of November 12, 2024. This is not a...
The U.S. government agency the Defense Health Agency (DHA) awarded a $2,875.65 fixed-price with economic price adjustment delivery order contract to Medtronic Inc., through its Medtronic USA, Inc. division, for the supply of BIOLOGICS - DBM-TS-OTI GRAFTON DBM MATRIX medical products. This contract does not have a set-aside designation. Medtronic is a global leader in medical technology, specializing in developing and manufacturing innovative medical devices and therapies. As a major supplier...
This is a $1,590.30 fixed-price with economic price adjustment delivery order awarded by the Defense Health Agency (DHA) to Medtronic Inc., a global medical technology company, through its Medtronic USA, Inc. division. The contract is for the procurement of BIOLOGICS - DBM-TS-OTI GRAFTON DBM MATRI, a type of surgical implant, with a period of performance ending on November 14, 2024. The award is not designated as a set-aside contract. Medtronic is a major supplier of advanced medical devices and...
This federal contract award was issued by the Medical Supply Chain, a component of the Defense Health Agency (DHA), to Medtronic Inc. through its Medtronic USA, Inc. division. The $11,650.80 fixed-price delivery order is for the supply of BIOLOGICS - DBM-TS-GRAFTON DBF, a biological medical product, with a completion date of May 15, 2024. The contract does not have a set-aside designation. Medtronic is a global leader in medical technology and has been awarded numerous firm fixed-price contracts...
This federal contract award to Medtronic Inc., through its Medtronic USA, Inc. division, is a Delivery Order (SPE2DE21D7001|SPE2D624F2PV9) with a ceiling value of $4,940.00. The contract is for the delivery of BIOLOGICS - DBM-TS-MAGNIFUSE DBM products, and has a fixed price with economic price adjustment pricing type. The award was made by the Defense Health Agency (DHA), which is a defense agency, with a period of performance through July 9, 2024. The contract does not have a set-aside...
This is a delivery order contract awarded by the Defense Health Agency (DHA), a component of the U.S. Department of Defense, to Medtronic Inc. through its Medtronic USA, Inc. division. The $4,940.00 fixed-price contract with economic price adjustment is for the supply of BIOLOGICS - DBM-TS-MAGNIFUSE DBM medical devices. This order is part of a larger Indefinite Delivery Contract (IDC) valued at up to $600 million that Medtronic holds with the Department of Veterans Affairs (VA) for providing a...